Minerva Neurosciences to Report First Quarter 2021 Financial Results and Business Updates on May 12, 2021
May 05, 2021 17:10 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
Minerva Neurosciences Reports Fiscal 2020 Fourth Quarter and Year End Financial Results and Business Updates
March 08, 2021 07:30 ET
|
Minerva Neurosciences, Inc
Phase 3 open-label extension completed on schedule in patients with negative symptoms of schizophrenia and data will be available in H1 2021 Minerva’s royalty interest in seltorexant acquired by...
Minerva Neurosciences to Report Fiscal 2020 Fourth Quarter and Year End Financial Results and Business Updates on March 8, 2021
March 01, 2021 08:30 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Minerva Neurosciences, Covia Holdings, Kandi, and Qiwi and Encourages Investors to Contact the Firm
February 03, 2021 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
BREAKING NOTICE: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Minerva Neurosciences, Inc. Investors with Large Losses to Secure Counsel Before Important February 8 Deadline – NERV
January 29, 2021 15:58 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 29, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Minerva Neurosciences, Covia Holdings, Semiconductor Manufacturing International Corporation, and Kandi Technologies and Encourages Investors to Contact the Firm
January 27, 2021 18:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Northern Dynasty Minerals, Splunk, Minerva Neurosciences, and Covia Holdings and Encourages Investors to Contact the Firm
January 20, 2021 18:00 ET
|
Bragar Eagel & Squire
NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Minerva Neurosciences and Royalty Pharma Announce Sale of Seltorexant Royalty for up to $155 Million
January 19, 2021 08:00 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass. and NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV) and Royalty Pharma plc (Nasdaq: RPRX) today announced that Royalty Pharma will acquire...
ROSEN, A LEADING LAW FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action – NERV
January 18, 2021 17:00 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 18, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...
ROSEN, A LEADING LAW FIRM, Reminds Minerva Neurosciences, Inc. Investors of Important February 8 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – NERV
January 14, 2021 12:06 ET
|
The Rosen Law Firm PA
NEW YORK, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Minerva Neurosciences, Inc. (NASDAQ: NERV) between May 15, 2017...